 | • レポートコード：MRC2-11QY05753 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はエポプロステノールのグローバル市場について調査・分析したレポートです。種類別（経口、注射）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別エポプロステノールの競争状況、市場シェア ・世界のエポプロステノール市場：種類別市場規模 2015年-2020年（経口、注射） ・世界のエポプロステノール市場：種類別市場規模予測 2021年-2026年（経口、注射） ・世界のエポプロステノール市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界のエポプロステノール市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米のエポプロステノール市場分析：米国、カナダ ・ヨーロッパのエポプロステノール市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのエポプロステノール市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のエポプロステノール市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのエポプロステノール市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Actelion、Glaxosmithkline Inc、Sandoz Canada Incorporated、Teva Parenteral、Bayer AG、SteadyMed、Reata Pharmaceuticals、Arena Pharmaceuticals、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Epoprostenol Market
The global Epoprostenol market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Epoprostenol Scope and Market Size
Epoprostenol market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Epoprostenol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Epoprostenol market is segmented into
Oral
Injection
Segment by Application, the Epoprostenol market is segmented into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regional and Country-level Analysis
The Epoprostenol market is analysed and market size information is provided by regions (countries).
The key regions covered in the Epoprostenol market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Epoprostenol Market Share Analysis
Epoprostenol market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Epoprostenol business, the date to enter into the Epoprostenol market, Epoprostenol product introduction, recent developments, etc.
The major vendors covered:
Actelion
Glaxosmithkline Inc
Sandoz Canada Incorporated
Teva Parenteral
Bayer AG
SteadyMed
Reata Pharmaceuticals
Arena Pharmaceuticals
Merck
1 Study Coverage
1.1 Epoprostenol Product Introduction
1.2 Market Segments
1.3 Key Epoprostenol Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Epoprostenol Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Epoprostenol Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Epoprostenol Market Size, Estimates and Forecasts
2.1.1 Global Epoprostenol Revenue 2015-2026
2.1.2 Global Epoprostenol Sales 2015-2026
2.2 Global Epoprostenol, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Epoprostenol Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Epoprostenol Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Epoprostenol Competitor Landscape by Players
3.1 Epoprostenol Sales by Manufacturers
3.1.1 Epoprostenol Sales by Manufacturers (2015-2020)
3.1.2 Epoprostenol Sales Market Share by Manufacturers (2015-2020)
3.2 Epoprostenol Revenue by Manufacturers
3.2.1 Epoprostenol Revenue by Manufacturers (2015-2020)
3.2.2 Epoprostenol Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Epoprostenol Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Epoprostenol Revenue in 2019
3.2.5 Global Epoprostenol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Epoprostenol Price by Manufacturers
3.4 Epoprostenol Manufacturing Base Distribution, Product Types
3.4.1 Epoprostenol Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Epoprostenol Product Type
3.4.3 Date of International Manufacturers Enter into Epoprostenol Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Epoprostenol Market Size by Type (2015-2020)
4.1.1 Global Epoprostenol Sales by Type (2015-2020)
4.1.2 Global Epoprostenol Revenue by Type (2015-2020)
4.1.3 Epoprostenol Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Epoprostenol Market Size Forecast by Type (2021-2026)
4.2.1 Global Epoprostenol Sales Forecast by Type (2021-2026)
4.2.2 Global Epoprostenol Revenue Forecast by Type (2021-2026)
4.2.3 Epoprostenol Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Epoprostenol Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Epoprostenol Market Size by Application (2015-2020)
5.1.1 Global Epoprostenol Sales by Application (2015-2020)
5.1.2 Global Epoprostenol Revenue by Application (2015-2020)
5.1.3 Epoprostenol Price by Application (2015-2020)
5.2 Epoprostenol Market Size Forecast by Application (2021-2026)
5.2.1 Global Epoprostenol Sales Forecast by Application (2021-2026)
5.2.2 Global Epoprostenol Revenue Forecast by Application (2021-2026)
5.2.3 Global Epoprostenol Price Forecast by Application (2021-2026)
6 North America
6.1 North America Epoprostenol by Country
6.1.1 North America Epoprostenol Sales by Country
6.1.2 North America Epoprostenol Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Epoprostenol Market Facts & Figures by Type
6.3 North America Epoprostenol Market Facts & Figures by Application
7 Europe
7.1 Europe Epoprostenol by Country
7.1.1 Europe Epoprostenol Sales by Country
7.1.2 Europe Epoprostenol Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Epoprostenol Market Facts & Figures by Type
7.3 Europe Epoprostenol Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Epoprostenol by Region
8.1.1 Asia Pacific Epoprostenol Sales by Region
8.1.2 Asia Pacific Epoprostenol Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Epoprostenol Market Facts & Figures by Type
8.3 Asia Pacific Epoprostenol Market Facts & Figures by Application
9 Latin America
9.1 Latin America Epoprostenol by Country
9.1.1 Latin America Epoprostenol Sales by Country
9.1.2 Latin America Epoprostenol Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Epoprostenol Market Facts & Figures by Type
9.3 Central & South America Epoprostenol Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Epoprostenol by Country
10.1.1 Middle East and Africa Epoprostenol Sales by Country
10.1.2 Middle East and Africa Epoprostenol Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Epoprostenol Market Facts & Figures by Type
10.3 Middle East and Africa Epoprostenol Market Facts & Figures by Application
11 Company Profiles
11.1 Actelion
11.1.1 Actelion Corporation Information
11.1.2 Actelion Description and Business Overview
11.1.3 Actelion Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Actelion Epoprostenol Products Offered
11.1.5 Actelion Related Developments
11.2 Glaxosmithkline Inc
11.2.1 Glaxosmithkline Inc Corporation Information
11.2.2 Glaxosmithkline Inc Description and Business Overview
11.2.3 Glaxosmithkline Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Glaxosmithkline Inc Epoprostenol Products Offered
11.2.5 Glaxosmithkline Inc Related Developments
11.3 Sandoz Canada Incorporated
11.3.1 Sandoz Canada Incorporated Corporation Information
11.3.2 Sandoz Canada Incorporated Description and Business Overview
11.3.3 Sandoz Canada Incorporated Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sandoz Canada Incorporated Epoprostenol Products Offered
11.3.5 Sandoz Canada Incorporated Related Developments
11.4 Teva Parenteral
11.4.1 Teva Parenteral Corporation Information
11.4.2 Teva Parenteral Description and Business Overview
11.4.3 Teva Parenteral Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Teva Parenteral Epoprostenol Products Offered
11.4.5 Teva Parenteral Related Developments
11.5 Bayer AG
11.5.1 Bayer AG Corporation Information
11.5.2 Bayer AG Description and Business Overview
11.5.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bayer AG Epoprostenol Products Offered
11.5.5 Bayer AG Related Developments
11.6 SteadyMed
11.6.1 SteadyMed Corporation Information
11.6.2 SteadyMed Description and Business Overview
11.6.3 SteadyMed Sales, Revenue and Gross Margin (2015-2020)
11.6.4 SteadyMed Epoprostenol Products Offered
11.6.5 SteadyMed Related Developments
11.7 Reata Pharmaceuticals
11.7.1 Reata Pharmaceuticals Corporation Information
11.7.2 Reata Pharmaceuticals Description and Business Overview
11.7.3 Reata Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Reata Pharmaceuticals Epoprostenol Products Offered
11.7.5 Reata Pharmaceuticals Related Developments
11.8 Arena Pharmaceuticals
11.8.1 Arena Pharmaceuticals Corporation Information
11.8.2 Arena Pharmaceuticals Description and Business Overview
11.8.3 Arena Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Arena Pharmaceuticals Epoprostenol Products Offered
11.8.5 Arena Pharmaceuticals Related Developments
11.9 Merck
11.9.1 Merck Corporation Information
11.9.2 Merck Description and Business Overview
11.9.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck Epoprostenol Products Offered
11.9.5 Merck Related Developments
11.1 Actelion
11.1.1 Actelion Corporation Information
11.1.2 Actelion Description and Business Overview
11.1.3 Actelion Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Actelion Epoprostenol Products Offered
11.1.5 Actelion Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Epoprostenol Market Estimates and Projections by Region
12.1.1 Global Epoprostenol Sales Forecast by Regions 2021-2026
12.1.2 Global Epoprostenol Revenue Forecast by Regions 2021-2026
12.2 North America Epoprostenol Market Size Forecast (2021-2026)
12.2.1 North America: Epoprostenol Sales Forecast (2021-2026)
12.2.2 North America: Epoprostenol Revenue Forecast (2021-2026)
12.2.3 North America: Epoprostenol Market Size Forecast by Country (2021-2026)
12.3 Europe Epoprostenol Market Size Forecast (2021-2026)
12.3.1 Europe: Epoprostenol Sales Forecast (2021-2026)
12.3.2 Europe: Epoprostenol Revenue Forecast (2021-2026)
12.3.3 Europe: Epoprostenol Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Epoprostenol Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Epoprostenol Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Epoprostenol Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Epoprostenol Market Size Forecast by Region (2021-2026)
12.5 Latin America Epoprostenol Market Size Forecast (2021-2026)
12.5.1 Latin America: Epoprostenol Sales Forecast (2021-2026)
12.5.2 Latin America: Epoprostenol Revenue Forecast (2021-2026)
12.5.3 Latin America: Epoprostenol Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Epoprostenol Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Epoprostenol Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Epoprostenol Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Epoprostenol Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Epoprostenol Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Epoprostenol Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Epoprostenol Market Segments
Table 2. Ranking of Global Top Epoprostenol Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Epoprostenol Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injection
Table 6. Global Epoprostenol Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Epoprostenol Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Epoprostenol Sales by Regions 2015-2020 (K MT)
Table 9. Global Epoprostenol Sales Market Share by Regions (2015-2020)
Table 10. Global Epoprostenol Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Epoprostenol Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Epoprostenol Sales Share by Manufacturers (2015-2020)
Table 13. Global Epoprostenol Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Epoprostenol by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epoprostenol as of 2019)
Table 15. Epoprostenol Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Epoprostenol Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Epoprostenol Price (2015-2020) (USD/MT)
Table 18. Epoprostenol Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Epoprostenol Product Type
Table 20. Date of International Manufacturers Enter into Epoprostenol Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Epoprostenol Sales by Type (2015-2020) (K MT)
Table 23. Global Epoprostenol Sales Share by Type (2015-2020)
Table 24. Global Epoprostenol Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Epoprostenol Revenue Share by Type (2015-2020)
Table 26. Epoprostenol Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Epoprostenol Sales by Application (2015-2020) (K MT)
Table 28. Global Epoprostenol Sales Share by Application (2015-2020)
Table 29. North America Epoprostenol Sales by Country (2015-2020) (K MT)
Table 30. North America Epoprostenol Sales Market Share by Country (2015-2020)
Table 31. North America Epoprostenol Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Epoprostenol Revenue Market Share by Country (2015-2020)
Table 33. North America Epoprostenol Sales by Type (2015-2020) (K MT)
Table 34. North America Epoprostenol Sales Market Share by Type (2015-2020)
Table 35. North America Epoprostenol Sales by Application (2015-2020) (K MT)
Table 36. North America Epoprostenol Sales Market Share by Application (2015-2020)
Table 37. Europe Epoprostenol Sales by Country (2015-2020) (K MT)
Table 38. Europe Epoprostenol Sales Market Share by Country (2015-2020)
Table 39. Europe Epoprostenol Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Epoprostenol Revenue Market Share by Country (2015-2020)
Table 41. Europe Epoprostenol Sales by Type (2015-2020) (K MT)
Table 42. Europe Epoprostenol Sales Market Share by Type (2015-2020)
Table 43. Europe Epoprostenol Sales by Application (2015-2020) (K MT)
Table 44. Europe Epoprostenol Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Epoprostenol Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Epoprostenol Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Epoprostenol Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Epoprostenol Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Epoprostenol Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Epoprostenol Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Epoprostenol Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Epoprostenol Sales Market Share by Application (2015-2020)
Table 53. Latin America Epoprostenol Sales by Country (2015-2020) (K MT)
Table 54. Latin America Epoprostenol Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Epoprostenol Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Epoprostenol Revenue Market Share by Country (2015-2020)
Table 57. Latin America Epoprostenol Sales by Type (2015-2020) (K MT)
Table 58. Latin America Epoprostenol Sales Market Share by Type (2015-2020)
Table 59. Latin America Epoprostenol Sales by Application (2015-2020) (K MT)
Table 60. Latin America Epoprostenol Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Epoprostenol Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Epoprostenol Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Epoprostenol Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Epoprostenol Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Epoprostenol Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Epoprostenol Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Epoprostenol Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Epoprostenol Sales Market Share by Application (2015-2020)
Table 69. Actelion Corporation Information
Table 70. Actelion Description and Major Businesses
Table 71. Actelion Epoprostenol Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Actelion Product
Table 73. Actelion Recent Development
Table 74. Glaxosmithkline Inc Corporation Information
Table 75. Glaxosmithkline Inc Description and Major Businesses
Table 76. Glaxosmithkline Inc Epoprostenol Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Glaxosmithkline Inc Product
Table 78. Glaxosmithkline Inc Recent Development
Table 79. Sandoz Canada Incorporated Corporation Information
Table 80. Sandoz Canada Incorporated Description and Major Businesses
Table 81. Sandoz Canada Incorporated Epoprostenol Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Sandoz Canada Incorporated Product
Table 83. Sandoz Canada Incorporated Recent Development
Table 84. Teva Parenteral Corporation Information
Table 85. Teva Parenteral Description and Major Businesses
Table 86. Teva Parenteral Epoprostenol Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Teva Parenteral Product
Table 88. Teva Parenteral Recent Development
Table 89. Bayer AG Corporation Information
Table 90. Bayer AG Description and Major Businesses
Table 91. Bayer AG Epoprostenol Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Bayer AG Product
Table 93. Bayer AG Recent Development
Table 94. SteadyMed Corporation Information
Table 95. SteadyMed Description and Major Businesses
Table 96. SteadyMed Epoprostenol Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. SteadyMed Product
Table 98. SteadyMed Recent Development
Table 99. Reata Pharmaceuticals Corporation Information
Table 100. Reata Pharmaceuticals Description and Major Businesses
Table 101. Reata Pharmaceuticals Epoprostenol Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Reata Pharmaceuticals Product
Table 103. Reata Pharmaceuticals Recent Development
Table 104. Arena Pharmaceuticals Corporation Information
Table 105. Arena Pharmaceuticals Description and Major Businesses
Table 106. Arena Pharmaceuticals Epoprostenol Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Arena Pharmaceuticals Product
Table 108. Arena Pharmaceuticals Recent Development
Table 109. Merck Corporation Information
Table 110. Merck Description and Major Businesses
Table 111. Merck Epoprostenol Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Merck Product
Table 113. Merck Recent Development
Table 114. Global Epoprostenol Sales Forecast by Regions (2021-2026) (K MT)
Table 115. Global Epoprostenol Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Epoprostenol Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Epoprostenol Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Epoprostenol Sales Forecast by Country (2021-2026) (K MT)
Table 119. North America: Epoprostenol Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Epoprostenol Sales Forecast by Country (2021-2026) (K MT)
Table 121. Europe: Epoprostenol Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Epoprostenol Sales Forecast by Region (2021-2026) (K MT)
Table 123. Asia Pacific: Epoprostenol Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Epoprostenol Sales Forecast by Country (2021-2026) (K MT)
Table 125. Latin America: Epoprostenol Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Epoprostenol Sales Forecast by Country (2021-2026) (K MT)
Table 127. Middle East and Africa: Epoprostenol Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Epoprostenol Players
Table 132. Epoprostenol Customers List
Table 133. Epoprostenol Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Epoprostenol Product Picture
Figure 2. Global Epoprostenol Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Epoprostenol Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Online Pharmacy
Figure 9. Epoprostenol Report Years Considered
Figure 10. Global Epoprostenol Market Size 2015-2026 (US$ Million)
Figure 11. Global Epoprostenol Sales 2015-2026 (K MT)
Figure 12. Global Epoprostenol Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Epoprostenol Sales Market Share by Region (2015-2020)
Figure 14. Global Epoprostenol Sales Market Share by Region in 2019
Figure 15. Global Epoprostenol Revenue Market Share by Region (2015-2020)
Figure 16. Global Epoprostenol Revenue Market Share by Region in 2019
Figure 17. Global Epoprostenol Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Epoprostenol Revenue in 2019
Figure 19. Epoprostenol Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Epoprostenol Sales Market Share by Type (2015-2020)
Figure 21. Global Epoprostenol Sales Market Share by Type in 2019
Figure 22. Global Epoprostenol Revenue Market Share by Type (2015-2020)
Figure 23. Global Epoprostenol Revenue Market Share by Type in 2019
Figure 24. Global Epoprostenol Market Share by Price Range (2015-2020)
Figure 25. Global Epoprostenol Sales Market Share by Application (2015-2020)
Figure 26. Global Epoprostenol Sales Market Share by Application in 2019
Figure 27. Global Epoprostenol Revenue Market Share by Application (2015-2020)
Figure 28. Global Epoprostenol Revenue Market Share by Application in 2019
Figure 29. North America Epoprostenol Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Epoprostenol Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Epoprostenol Sales Market Share by Country in 2019
Figure 32. North America Epoprostenol Revenue Market Share by Country in 2019
Figure 33. U.S. Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Epoprostenol Market Share by Type in 2019
Figure 38. North America Epoprostenol Market Share by Application in 2019
Figure 39. Europe Epoprostenol Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Epoprostenol Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Epoprostenol Sales Market Share by Country in 2019
Figure 42. Europe Epoprostenol Revenue Market Share by Country in 2019
Figure 43. Germany Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Epoprostenol Market Share by Type in 2019
Figure 54. Europe Epoprostenol Market Share by Application in 2019
Figure 55. Asia Pacific Epoprostenol Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Epoprostenol Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Epoprostenol Sales Market Share by Region in 2019
Figure 58. Asia Pacific Epoprostenol Revenue Market Share by Region in 2019
Figure 59. China Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Epoprostenol Market Share by Type in 2019
Figure 82. Asia Pacific Epoprostenol Market Share by Application in 2019
Figure 83. Latin America Epoprostenol Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Epoprostenol Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Epoprostenol Sales Market Share by Country in 2019
Figure 86. Latin America Epoprostenol Revenue Market Share by Country in 2019
Figure 87. Mexico Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Epoprostenol Market Share by Type in 2019
Figure 94. Latin America Epoprostenol Market Share by Application in 2019
Figure 95. Middle East and Africa Epoprostenol Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Epoprostenol Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Epoprostenol Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Epoprostenol Revenue Market Share by Country in 2019
Figure 99. Turkey Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Epoprostenol Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Epoprostenol Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Epoprostenol Market Share by Type in 2019
Figure 106. Middle East and Africa Epoprostenol Market Share by Application in 2019
Figure 107. North America Epoprostenol Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Epoprostenol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Epoprostenol Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Epoprostenol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Epoprostenol Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Epoprostenol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Epoprostenol Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Epoprostenol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Epoprostenol Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Epoprostenol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
非滅菌調剤薬の世界市場（～2026年） Nonsterile drug compounding is the practice of preparing specific medication doses for patients to drink, swallow, insert or apply to the skin. It is the most common kind of drug compounding done by pharmacists and pharmacy technicians in community and hospital pharmacies. And despite its "nonsteril…- 外来患者用調剤自動化の世界市場（～2026年） The outpatient pharmacy automation system is a series of automated computer controlled workflows that minimize errors in pharmaceutical processes such as packaging and distribution. With the growing focus to reduce staffing and cut costs, there is a rise in the adoption of automation in the healthca…
- 動物用薬剤配合の世界市場（～2026年） Compounding is the mixing of drugs to fit the unique needs of a patient. AHI and AVMA define it as “customized manipulation of an approved drug or drugs by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs of a particular patient. Animal drug shortages are…
- ビタミン欠乏症治療の世界市場（～2026年） Vitamin deficiency, also called as hypovitaminosis, is primarily caused by malnutrition. The global vitamin deficiency treatment market is highly fragmented with large number of local as well as strong players. Market Analysis and Insights: Global Vitamin Deficiency Treatment Market The global Vitam…
- バイオ医薬品経口ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Biopharmaceutical Oral Drug Delivery Market The global Biopharmaceutical Oral Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Biopharmaceutical Oral Drug Delivery Scop…